Brisbane biotech company with 140 patents

    • Innovation Australia’s Mission

      A registrant company, in its registration application, may nominate more than one Australian and New Zealand Standard Research Classification to which its R&D activities relate. As a result, a registrant company will be counted more than once if the company participated in two or more projects under different ANZSRC classifications.

    • [DOC File]Annual Report 2017-18 - City of Melbourne

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_18e6c5.html

      Growth in the number of new patents per year. 16.8% decrease There was around a 17 per cent decrease in patent numbers from 112 to 93 in the municipality. This figure has been calculated by the change in the number of new patents in 2016 from the number of new patents in 2015, presented as a percentage (2016 is the most recent data available).

    • tatement of Principles for Australian Innovation Precincts

      Australia enjoys a reputation as the ‘lucky country,’ enjoying prosperity thanks to natural endowments and good fortune. This Statement of Principles, as part of the Government’s broader innovation agenda, will encourage the right settings for precinct development as an important part of Australia’s innovation system, making it easier for us to make our own luck and secure this ...

    • CONTENTS

      Biotech start-up Coridon is preparing to take its DNA vaccine for herpes simplex virus type 2, or genital herpes, into Phase 1 clinical trials. Coridon has worked with UniQuest for more than 10 years to progress the vaccine, which incorporates a patented platform technology for the next generation of DNA vaccines developed by UQ’s Professor ...

    • Investor Overview | Protagonist Therapeutics, Inc.

      The Company determined that the transaction price of the initial performance obligation as of September 30, 2020 includes the $50.0 million upfront payment, the $25.0 million payment received upon the effectiveness of the First Amendment, the $5.0 million payment triggered by the successful nomination of a second-generation compound, $18.4 ...

    • [DOC File]Industry Innovation and Competitiveness Agenda

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_1ca055.html

      KPMG estimates that for every $1 collected through company tax, more than 23 cents of value is lost to the economy (KPMG, 2010). Although dividend imputation reduces the burden of company tax in Australia for domestic shareholders, at 30 per cent our company tax rate is high by international standards (Chart 10).

    • [DOC File]BUSINESS MATCHING AT BIO 2005

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_0c5361.html

      Founded in Brisbane, Australia, in 2003, the company's research center and corporate headquarters are located at the University of Queensland. Competitive Advantages Key patents related to plant promoters, plant architecture and delayed ripening.

    • [DOC File]CRDC Annual Report 2017-2018

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_e413b9.html

      In 2016-17, CRDC began working in the entrepreneurial space with start-up science company Pollenizer, and its successor, X-Lab. CRDC’s work to incubate potential cotton start-ups and entrepreneurs gained strength in 2017-18, with the continuation of the X-Lab partnership.

    • Investor Overview | Protagonist Therapeutics, Inc.

      Protagonist Pty Limited (“Protagonist Australia”) is a wholly-owned subsidiary of the Company and is located in Brisbane, Queensland, Australia. Protagonist Australia was incorporated in Australia in September 2001. The Company manages its operations as a single operating segment. Liquidity

    • [DOC File]July 2, 1996 - Anderson Lab

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_82d5cf.html

      Patents: Medarex, Inc. 1985. In the early 1980s I along with Michael Fanger and Paul Guyre of Dartmouth collaborated to start a biotech company to develop two monoclonal antibodies that I had made with their help, mabs 32 and IV.3, directed toward human Fc receptors, antibodies on which I and U of Rochester colleagues held the patents.

    • POLLUTION RESEARCH GROUP

      BROUCKAERT, C.J., MAJOZI, T., GARDNER, G. and BUCKLEY, C.A., `The Application of Pinch Analysis to Water and Effluent Management in the Process Industry', 2nd Asia-Pacific Cleaner Production Roundtable and Trade Expo, Global Competitiveness Through Cleaner Production, Brisbane Convention & Exhibition Centre, Brisbane, Australia, 21-24 April 1999.

    • [DOC File]CRDC Annual Report 2014-15

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_bb8941.html

      The cotton industry has the necessary science to provide informed input into the development of resistance management plans for biotech traits. The cotton industry demonstrates pesticide management practices that lower the risks posed to the environment and the evolution of resistance in target insect pest and weed populations.

    • [DOC File]cv for Ben Gurion DARGA

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_77bee1.html

      Masculine sex differentiation pathways in the fresh water prawn Macrobrachium rossenbrgii, a hinge around the major component, insulin- like androgenic gland hormone (Mr-IAG). 10th International Marine Biotechnology Conference (IMBC), Brisbane, Australia.

    • [DOCX File]c-Myc literatures

      https://info.5y1.org/brisbane-biotech-company-with-140-patents_1_cf1886.html

      , and a US-based biotech company, Vical Incorporated, published work in 1989 demonstrating that mRNA, using a liposomal. nanoparticle for drug delivery, could transfect. mRNA into a variety of eukaryotic cells. In 1990, the University of Wisconsin, reported positive results where "naked" (or unprotected) mRNA was injected into the muscle of mice.

Nearby & related entries:

To fulfill the demand for quickly locating and searching documents.

It is intelligent file search solution for home and business.

Literature Lottery

Advertisement
Hot searches

©2024 5y1.org, Inc. All rights reserved.